Simplex Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-24,695
Closed -$2.45M 8503
2019
Q3
$2.45M Buy
24,695
+24,022
+3,569% +$2.28M 0.01% 1180
2019
Q2
$62K Buy
673
+573
+573% +$54.4K ﹤0.01% 4680
2019
Q1
$9K Sell
100
-67,137
-100% -$5.87M ﹤0.01% 6254
2018
Q4
$4.31M Buy
67,237
+57,070
+561% +$4.21M 0.01% 641
2018
Q3
$909K Sell
10,167
-115,491
-92% -$10.2M ﹤0.01% 1991
2018
Q2
$9.98M Buy
125,658
+31,934
+34% +$2.65M 0.04% 345
2018
Q1
$8.36M Sell
93,724
-186,470
-67% -$17.9M 0.37% 47
2017
Q4
$29.2M Buy
+280,194
New +$31.6M 1.26% 5
2017
Q3
Sell
-76,819
Closed -$10.5M 7305
2017
Q2
$9.98M Buy
76,819
+4,126
+6% +$506K 0.43% 36
2017
Q1
$9.04M Buy
72,693
+57,546
+380% +$6.89M 0.39% 38
2016
Q4
$1.75M Buy
+15,147
New +$1.69M 0.1% 162
2016
Q3
Sell
-116,614
Closed -$12.6M 7146
2016
Q2
$11.5M Buy
116,614
+107,696
+1,208% +$11.1M 0.77% 14
2016
Q1
$892K Sell
8,918
-33,025
-79% -$3.4M 0.07% 252
2015
Q4
$5.02M Sell
41,943
-9,706
-19% -$1.12M 0.39% 41
2015
Q3
$5.59M Sell
51,649
-34,770
-40% -$4.31M 0.41% 49
2015
Q2
$10M Buy
86,419
+45,234
+110% +$5.17M 0.84% 13
2015
Q1
$4.75M Buy
41,185
+15,114
+58% +$1.81M 0.55% 24
2014
Q4
$2.92M Buy
+26,071
New +$2.75M 0.35% 46

Other funds holding CELG

Simplex Trading's CELG Position: Q4 2019 in Review

Simplex Trading sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 24,695 shares — an estimated $2.45M sold.

Simplex Trading first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $29.2M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Simplex Trading reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 24,695 Celgene Corp shares in Q4 2019, an estimated $2.45M.
  • Simplex Trading first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • Simplex Trading's Celgene Corp position peaked at $29.2M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.